Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs under Development.

about

Selectivity, cell permeability and oral availability studies of novel bromophenol derivative HPN as protein tyrosine phosphatase 1B inhibitor.

P2860

Q47615563-9297F870-D716-4E2D-98C6-DE56D530D8C7

P2860

Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs under Development.

Item

http://www.wikidata.org/entity/Q38806457

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs under Development.

@en

type

Item

label

Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs under Development.

@en

prefLabel

Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs under Development.

@en

P1476

Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs under Development.

@en

P2093

Claudia De Oliveira

http://www.w3.org/2001/XMLSchema#string

Erica Caveney

http://www.w3.org/2001/XMLSchema#string

Friedrich Mittermayer

http://www.w3.org/2001/XMLSchema#string

G Alexander Fleming

http://www.w3.org/2001/XMLSchema#string

J Rick Turner

http://www.w3.org/2001/XMLSchema#string

Li-Jung Tai

http://www.w3.org/2001/XMLSchema#string

Loukas Gourgiotis

http://www.w3.org/2001/XMLSchema#string

Mala Puri

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

Regenerating proteins and their expression, regulation, and signaling

Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity

Addressing unmet medical needs in type 2 diabetes: a narrative review of drugs under development

Expanding the clinical indications for α(1)-antitrypsin therapy

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010

Amelioration of type 1 diabetes following treatment of non-obese diabetic mice with INGAP and lisofylline.

Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.

P304

300-314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2174/1573399812666160413115655

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2016-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27071617

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

biomedical investigative technique

P932

5748875

http://www.w3.org/2001/XMLSchema#string

Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs under Development.

about

P2860

P2860

Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs under Development.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932